What does the 75,747-share Form 4 transaction for Nutex Health (NUTX) represent?

The 75,747-share transaction represents issuance in a private transaction of 62,994 and 12,753 Nutex Health common shares. It relates to one-time obligations tied to Thomas T. Vo’s pro-rata share of two under-construction hospitals transferred under a prior Agreement and Plan of Merger.

Nutex Health (NUTX) CEO reports 75,747-share restructuring via Micro Hospital Holdings

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Nutex Health Inc. director and CEO Thomas T. Vo reported an "other" Form 4 transaction involving 75,747 shares of common stock held indirectly through Micro Hospital Holdings LLC. The shares were issued in a private transaction to satisfy one-time obligations tied to two under-construction hospitals.

Following this restructuring-related issuance, Micro Hospital Holdings LLC is shown as holding 2,103,014 Nutex Health common shares indirectly for Vo, who owns and controls the LLC.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Vo Thomas T.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Other	Common Stock	75,747	$0.00	--

Holdings After Transaction: Common Stock — 2,103,014 shares (Indirect, By Micro Hospital Holdings LLC)

Footnotes (1)

Represents the issuance in private transaction of 62,994 and 12,753 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of two under construction hospitals previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026. Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein.

Key Figures

Restructuring shares: 75,747 shares Private issuance tranche 1: 62,994 shares Private issuance tranche 2: 12,753 shares +1 more

4 metrics

Restructuring shares 75,747 shares Other acquisition or disposition on Form 4

Private issuance tranche 1 62,994 shares Part of one-time obligation settlement

Private issuance tranche 2 12,753 shares Part of one-time obligation settlement

Shares held after transaction 2,103,014 shares Indirectly via Micro Hospital Holdings LLC following transaction

Key Terms

Form 4, indirect ownership, Agreement and Plan of Merger, definitive proxy statement, +1 more

5 terms

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

indirect ownership financial

"direct_or_indirect": "I","nature_of_ownership": "By Micro Hospital Holdings LLC""

Agreement and Plan of Merger regulatory

"previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021"

An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.

definitive proxy statement regulatory

"described in the Issuer's definitive proxy statement on Schedule 14A filed"

A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.

Schedule 14A regulatory

"definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission"

Schedule 14A is a document that companies file with regulators to share important information with shareholders before a big vote, like approving a merger or election of directors. It matters because it helps investors understand what’s happening so they can make informed decisions about the company’s future.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

05/29/2026 - 01:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vo Thomas T.

(Last)

(First)

(Middle)

1776 YORKTOWN STREET SUITE 700

C/O NUTEX HEALTH INC.

(Street)

HOUSTON

TEXAS

77056

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/28/2026		J		75,747	A	$0⁽¹⁾	2,103,014	I	By Micro Hospital Holdings LLC⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the issuance in private transaction of 62,994 and 12,753 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of two under construction hospitals previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.

2. Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein.

	/s/ Thomas Vo	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Nutex Health (NUTX) report for Thomas T. Vo?

Thomas T. Vo reported an "other" Form 4 transaction for 75,747 Nutex Health common shares. These shares were issued in a private transaction to Micro Hospital Holdings LLC to satisfy one-time obligations related to two under-construction hospitals.

How many Nutex Health (NUTX) shares are now indirectly held after this Form 4?

After the reported transaction, 2,103,014 Nutex Health common shares are indirectly held through Micro Hospital Holdings LLC. This figure reflects holdings following the private issuance connected to obligations for two under-construction hospitals previously transferred to Nutex Health Holdco LLC.

Who actually holds the Nutex Health (NUTX) shares reported in this Form 4?

The reported Nutex Health shares are held indirectly through Micro Hospital Holdings LLC. Footnotes state that Thomas T. Vo, Nutex Health’s Chairman and CEO, owns and controls Micro Hospital Holdings LLC, which is the direct owner of the securities listed in the Form 4.

Was the Nutex Health (NUTX) Form 4 transaction a market buy or sell?

The Form 4 uses transaction code J, labeled as "Other acquisition or disposition," not a standard market buy or sell. It describes a restructuring-type private issuance to satisfy specific one-time obligations linked to two under-construction hospitals, rather than open-market trading.

How is the Nutex Health (NUTX) Form 4 transaction linked to prior merger agreements?

The footnotes tie this issuance to obligations from an Agreement and Plan of Merger dated November 23, 2021. Those obligations relate to Thomas T. Vo’s pro-rata share of two under-construction hospitals previously transferred to Nutex Health Holdco LLC under that merger structure.